Our results contrast with studies that showed reduced expression and function of ABCG1 (but not ABCA1) in monocytes and macrophages in people with T2DM [27], [28], but these earlier studies were not designed or conducted in drug naive patients who were free of complications. The gene discussed is ABCG1; the disease is type 2 diabetes mellitus.